IKS Health Announces $557M TruBridge Acquisition Under Regulation 30
Inventurus Knowledge Solutions' U.S. subsidiary IKS Health has announced a definitive agreement to acquire 100% of TruBridge Inc. for $557M enterprise value, funded through a $600M debt facility. The transaction combines TruBridge's EHR and RCM services ($347M revenue, $69M adjusted EBITDA) with IKS Health's care enablement platform, targeting rural hospitals and expected to close in Q2 FY27.

*this image is generated using AI for illustrative purposes only.
Inventurus Knowledge Solutions has announced a major strategic acquisition through its U.S. subsidiary IKS Health, which has entered into a definitive agreement to acquire 100% of TruBridge Inc. The announcement was made under Regulation 30 of SEBI regulations on April 23, 2026, marking a significant milestone in the company's expansion strategy.
Transaction Overview
The acquisition represents a substantial investment in the healthcare technology sector, with IKS Health proposing to take TruBridge private through a comprehensive buyout structure.
| Transaction Parameter: | Details |
|---|---|
| Enterprise Value: | $557M |
| Equity Component: | $427M |
| Debt Component: | $130M |
| Funding Source: | $600M debt facility |
| Interest Rate: | SOFR+275 bps (sliding to 175 bps) |
| Leverage Ratio: | ≈3X EBITDA |
TruBridge Business Profile
TruBridge operates as a fully integrated Revenue Cycle Management (RCM) and Electronic Health Records (EHR) vendor, primarily serving mid-small hospitals and rural healthcare facilities across the United States.
| Business Segment: | Revenue (USD Million) | Key Metrics |
|---|---|---|
| EHR Services: | $126M | ~1,500 clients |
| RCM Services: | $221M | ~3,700 employees |
| Total Revenue: | $347M | 6% CAGR (2020-2025) |
| Adjusted EBITDA: | $69M | 10% CAGR (2020-2025) |
Strategic Rationale and Market Position
The acquisition aligns with IKS Health's vision to create an integrated healthcare operating system combining System of Record (EHR) with System of Action (AI-powered care enablement platform). TruBridge brings significant market presence in rural hospitals, with 40%+ presence in facilities with less than 50 beds and coverage of 25-30% of all rural hospitals.
Financial Impact and Timeline
The transaction is expected to be PAT and EPS accretive in FY27, with the combined entity projected to achieve 26% proforma adjusted EBITDA. The deal includes provisions for ESOP cost elimination of $9.4 million and removal of certain non-recurring public company expenses.
| Timeline Milestone: | Expected Period |
|---|---|
| Definitive Agreement: | April 23, 2026 |
| Pre-close Phase: | 90-120 days |
| Transaction Close: | Q2 FY27 |
| Integration Phase: | 4-5 quarters post-closing |
The acquisition will be funded through a 5-year debt facility with initial interest costs at SOFR+275 basis points, scaling down to 175 basis points as leverage reduces. The company expects to maintain leverage at approximately 3X EBITDA of the combined entity.
Historical Stock Returns for Inventurus Knowledge Solutions
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.19% | -5.54% | +12.79% | -5.80% | -5.28% | -26.66% |
How will the integration of TruBridge's EHR capabilities with IKS Health's AI-powered platform differentiate them from competitors like Epic and Cerner in the rural healthcare market?
What regulatory hurdles might the acquisition face given the consolidation concerns in healthcare technology, and how could this impact the Q2 FY27 closing timeline?
Will IKS Health pursue additional acquisitions in the healthcare RCM space to leverage the debt facility, or focus solely on organic growth post-TruBridge integration?


































